Sarepta Therapeutics News

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael

Dec 30, 2024 20:05 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf

Dec 16, 2024 20:03 ET

Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 12, 2024 17:11 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean

Dec 6, 2024 20:05 ET

Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 5, 2024 16:20 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin

Nov 29, 2024 20:19 ET

Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rothfuss Cristin

Nov 29, 2024 20:04 ET

Sarepta Therapeutics | 8-K: Current report

Nov 26, 2024 07:22 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise

Nov 20, 2024 20:02 ET

Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(4.6%)

Nov 14, 2024 09:46 ET

Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital International Investors(6.7%)

Nov 13, 2024 10:33 ET

Sarepta Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:09 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Connelly Deirdre P

Sep 16, 2024 20:07 ET

Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Connelly Deirdre P

Sep 16, 2024 20:02 ET

Sarepta Therapeutics | 8-K: Current report

Sep 16, 2024 08:56 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN

Sep 5, 2024 20:03 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael

Sep 3, 2024 20:02 ET

Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 30, 2024 17:08 ET

Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chambers Michael Andrew

Aug 20, 2024 08:03 ET

Sarepta Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 7, 2024 16:57 ET